450 related articles for article (PubMed ID: 27517146)
1. The role of nerve microenvironment for neurofibroma development.
Liao CP; Pradhan S; Chen Z; Patel AJ; Booker RC; Le LQ
Oncotarget; 2016 Sep; 7(38):61500-61508. PubMed ID: 27517146
[TBL] [Abstract][Full Text] [Related]
2. Susceptible stages in Schwann cells for NF1-associated plexiform neurofibroma development.
Le LQ; Liu C; Shipman T; Chen Z; Suter U; Parada LF
Cancer Res; 2011 Jul; 71(13):4686-95. PubMed ID: 21551250
[TBL] [Abstract][Full Text] [Related]
3. Plexiform and dermal neurofibromas and pigmentation are caused by Nf1 loss in desert hedgehog-expressing cells.
Wu J; Williams JP; Rizvi TA; Kordich JJ; Witte D; Meijer D; Stemmer-Rachamimov AO; Cancelas JA; Ratner N
Cancer Cell; 2008 Feb; 13(2):105-16. PubMed ID: 18242511
[TBL] [Abstract][Full Text] [Related]
4. Genetically engineered mouse models shed new light on the pathogenesis of neurofibromatosis type I-related neoplasms of the peripheral nervous system.
Brossier NM; Carroll SL
Brain Res Bull; 2012 May; 88(1):58-71. PubMed ID: 21855613
[TBL] [Abstract][Full Text] [Related]
5. The angiogenic factor midkine is aberrantly expressed in NF1-deficient Schwann cells and is a mitogen for neurofibroma-derived cells.
Mashour GA; Ratner N; Khan GA; Wang HL; Martuza RL; Kurtz A
Oncogene; 2001 Jan; 20(1):97-105. PubMed ID: 11244508
[TBL] [Abstract][Full Text] [Related]
6. Neurofibromatosis Type 1 and tumorigenesis: molecular mechanisms and therapeutic implications.
Gottfried ON; Viskochil DH; Couldwell WT
Neurosurg Focus; 2010 Jan; 28(1):E8. PubMed ID: 20043723
[TBL] [Abstract][Full Text] [Related]
7. Runx1 contributes to neurofibromatosis type 1 neurofibroma formation.
Li H; Zhao X; Yan X; Jessen WJ; Kim MO; Dombi E; Liu PP; Huang G; Wu J
Oncogene; 2016 Mar; 35(11):1468-74. PubMed ID: 26073082
[TBL] [Abstract][Full Text] [Related]
8. Role for the epidermal growth factor receptor in neurofibromatosis-related peripheral nerve tumorigenesis.
Ling BC; Wu J; Miller SJ; Monk KR; Shamekh R; Rizvi TA; Decourten-Myers G; Vogel KS; DeClue JE; Ratner N
Cancer Cell; 2005 Jan; 7(1):65-75. PubMed ID: 15652750
[TBL] [Abstract][Full Text] [Related]
9. Molecular, genetic, and cellular pathogenesis of neurofibromas and surgical implications.
Gottfried ON; Viskochil DH; Fults DW; Couldwell WT
Neurosurgery; 2006 Jan; 58(1):1-16; discussion 1-16. PubMed ID: 16385324
[TBL] [Abstract][Full Text] [Related]
10. Cells of origin in the embryonic nerve roots for NF1-associated plexiform neurofibroma.
Chen Z; Liu C; Patel AJ; Liao CP; Wang Y; Le LQ
Cancer Cell; 2014 Nov; 26(5):695-706. PubMed ID: 25446898
[TBL] [Abstract][Full Text] [Related]
11. Neurofibromas in NF1: Schwann cell origin and role of tumor environment.
Zhu Y; Ghosh P; Charnay P; Burns DK; Parada LF
Science; 2002 May; 296(5569):920-2. PubMed ID: 11988578
[TBL] [Abstract][Full Text] [Related]
12. Plexiform-like neurofibromas develop in the mouse by intraneural xenograft of an NF1 tumor-derived Schwann cell line.
Perrin GQ; Fishbein L; Thomson SA; Thomas SL; Stephens K; Garbern JY; DeVries GH; Yachnis AT; Wallace MR; Muir D
J Neurosci Res; 2007 May; 85(6):1347-57. PubMed ID: 17335073
[TBL] [Abstract][Full Text] [Related]
13. Decreased expression of neurofibromin contributes to epithelial-mesenchymal transition in neurofibromatosis type 1.
Arima Y; Hayashi H; Kamata K; Goto TM; Sasaki M; Kuramochi A; Saya H
Exp Dermatol; 2010 Aug; 19(8):e136-41. PubMed ID: 20002172
[TBL] [Abstract][Full Text] [Related]
14. Insertional Mutagenesis Identifies a STAT3/Arid1b/β-catenin Pathway Driving Neurofibroma Initiation.
Wu J; Keng VW; Patmore DM; Kendall JJ; Patel AV; Jousma E; Jessen WJ; Choi K; Tschida BR; Silverstein KA; Fan D; Schwartz EB; Fuchs JR; Zou Y; Kim MO; Dombi E; Levy DE; Huang G; Cancelas JA; Stemmer-Rachamimov AO; Spinner RJ; Largaespada DA; Ratner N
Cell Rep; 2016 Mar; 14(8):1979-90. PubMed ID: 26904939
[TBL] [Abstract][Full Text] [Related]
15. Zebrafish neurofibromatosis type 1 genes have redundant functions in tumorigenesis and embryonic development.
Shin J; Padmanabhan A; de Groh ED; Lee JS; Haidar S; Dahlberg S; Guo F; He S; Wolman MA; Granato M; Lawson ND; Wolfe SA; Kim SH; Solnica-Krezel L; Kanki JP; Ligon KL; Epstein JA; Look AT
Dis Model Mech; 2012 Nov; 5(6):881-94. PubMed ID: 22773753
[TBL] [Abstract][Full Text] [Related]
16. Tumor microenvironment and neurofibromatosis type I: connecting the GAPs.
Le LQ; Parada LF
Oncogene; 2007 Jul; 26(32):4609-16. PubMed ID: 17297459
[TBL] [Abstract][Full Text] [Related]
17. Contributions of inflammation and tumor microenvironment to neurofibroma tumorigenesis.
Liao CP; Booker RC; Brosseau JP; Chen Z; Mo J; Tchegnon E; Wang Y; Clapp DW; Le LQ
J Clin Invest; 2018 Jul; 128(7):2848-2861. PubMed ID: 29596064
[TBL] [Abstract][Full Text] [Related]
18. Induction of abnormal proliferation by nonmyelinating schwann cells triggers neurofibroma formation.
Zheng H; Chang L; Patel N; Yang J; Lowe L; Burns DK; Zhu Y
Cancer Cell; 2008 Feb; 13(2):117-28. PubMed ID: 18242512
[TBL] [Abstract][Full Text] [Related]
19. Nf1-dependent tumors require a microenvironment containing Nf1+/-- and c-kit-dependent bone marrow.
Yang FC; Ingram DA; Chen S; Zhu Y; Yuan J; Li X; Yang X; Knowles S; Horn W; Li Y; Zhang S; Yang Y; Vakili ST; Yu M; Burns D; Robertson K; Hutchins G; Parada LF; Clapp DW
Cell; 2008 Oct; 135(3):437-48. PubMed ID: 18984156
[TBL] [Abstract][Full Text] [Related]
20. Spatiotemporal Loss of
Chen Z; Mo J; Brosseau JP; Shipman T; Wang Y; Liao CP; Cooper JM; Allaway RJ; Gosline SJC; Guinney J; Carroll TJ; Le LQ
Cancer Discov; 2019 Jan; 9(1):114-129. PubMed ID: 30348677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
